Plegridy Satisfaction Study in Participants
NCT02587065
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
193
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing-Remitting Multiple Sclerosis (RRMS)
Interventions
DRUG:
peginterferon beta-1a
Sponsor
Biogen